Literature DB >> 25208228

Overlapping between CYP3A4 and CYP3A7 expression in the fetal human liver during development.

Daniela Fanni1, Vassillios Fanos2, Rossano Ambu1, Federica Lai1, Clara Gerosa1, Pietro Pampaloni1, Peter Van Eyken3, Giancarlo Senes1, Massimo Castagnola4, Gavino Faa1.   

Abstract

OBJECTIVE: The cytochrome P450 (CYP450) superfamily is implicated in important life processes, including metabolism of many molecules. CYP3A account for the largest portion of CYP450 proteins in human, including CYP3A4, CYP3A5 and CYP3A7. The purpose of this study was to investigate the immunohistochemical expression of CYP3A4 and CYP3A7 in human liver at different post-conceptional (PC) ages.
METHODS: Human liver samples from 30 fetuses and newborns were, clustered according with the PC age, routinely processed for immunohistochemical analysis of CYP3A4 and CYP3A7.
RESULTS: CYP3A4 was positive in all but two cases, CYP3A7 was positive in all but one case, which was negative also for CYP3A4.
CONCLUSIONS: Our data on immunohistochemical detection of CYP3A4 and CYP3A7 during development show that CYP3A4 expression is not restricted to the post-natal age, being the immunostaining for both CYP3A4 and CYP3A7 identical after 25 weeks of PC age, thus the relationship between these CYP450 isoforms should be considered much more complex than previous thought. A high interindividual variability was observed among subjects at all gestational age. The variable CYP3A expression suggests the existence of a marked interindividual variability in drug metabolism during the intrauterine life and in perinatal period.

Entities:  

Keywords:  CYP3A4; CYP3A7; cytochrome P450; fetus; immunohistochemistry; liver; newborns

Year:  2014        PMID: 25208228     DOI: 10.3109/14767058.2014.951625

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  5 in total

Review 1.  Fetal Physiologically Based Pharmacokinetic Models: Systems Information on the Growth and Composition of Fetal Organs.

Authors:  Khaled Abduljalil; Masoud Jamei; Trevor N Johnson
Journal:  Clin Pharmacokinet       Date:  2019-02       Impact factor: 6.447

2.  A Physiologically-Based Pharmacokinetic Model to Predict Human Fetal Exposure for a Drug Metabolized by Several CYP450 Pathways.

Authors:  Maïlys De Sousa Mendes; Gabrielle Lui; Yi Zheng; Claire Pressiat; Deborah Hirt; Elodie Valade; Naïm Bouazza; Frantz Foissac; Stephane Blanche; Jean-Marc Treluyer; Saik Urien; Sihem Benaboud
Journal:  Clin Pharmacokinet       Date:  2017-05       Impact factor: 6.447

Review 3.  Stem/progenitor cells in fetuses and newborns: overview of immunohistochemical markers.

Authors:  D Fanni; C Gerosa; C Loddo; M Castagnola; V Fanos; M Zaffanello; G Faa
Journal:  Cell Regen       Date:  2021-07-05

4.  Immunohistochemical markers of CYP3A4 and CYP3A7: a new tool towards personalized pharmacotherapy of hepatocellular carcinoma.

Authors:  D Fanni; M Manchia; F Lai; C Gerosa; R Ambu; G Faa
Journal:  Eur J Histochem       Date:  2016-04-11       Impact factor: 3.188

Review 5.  The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key?

Authors:  Aizati N A Daud; Jorieke E H Bergman; Wilhelmina S Kerstjens-Frederikse; Henk Groen; Bob Wilffert
Journal:  Int J Mol Sci       Date:  2016-08-13       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.